TransMedics Group (TMDX) Tops Q4 EPS by 19c, provides guidance

TransMedics Group (NASDAQ: TMDX) reported Q4 EPS of $0.12, $0.19 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $81.2 million versus the consensus estimate of $68.49 million.

GUIDANCE:

TransMedics Group sees FY2024 revenue of $360-370 million, versus the consensus of $330.2 million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue